Skip to main content
    C

    Centene Corp (CNC)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $74.78
    +3.51 (+4.92%)

    Market Cap: $35.28B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Centene Corp (CNC) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Centene (CNC) trades at 14.2x trailing earnings and 0.2x sales. Its P/E of 14.2x is above its 5-year median of 11.4x. Its forward P/E is 12.6x. The median P/E across 12 similar companies is 18.6x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 12.7% higher over the next year. Its free cash flow yield is 10.7%.

    MultipleValue
    P/E (trailing)14.2x
    Forward P/E12.6x
    Price to sales0.2x
    Price to book1.7x
    EV/EBITDA14.2x
    Price to FCF9.4x
    EV/FCF8.1x
    PEG0.8
    FCF yield10.7%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 7.6% above 13.2x, its P/S is 33.3% below 0.3x and its P/B is 6.3% above 1.6x.

    MultipleCurrent5-year median10-year median
    P/E14.2x11.4x13.2x
    P/S0.2x0.3x0.3x
    P/B1.7x1.4x1.6x
    Medians of month-end values through Oct 2026: 55 to 60 months (5-year) and 115 to 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 8.5x in 2024 to 20.1x in 2025. 2025 was the highest of those years.

    Year endPriceP/EP/SP/B
    2025$41.1520.1x0.1x1.0x
    2024$60.588.5x0.2x1.2x
    2023$74.2111.1x0.3x1.5x
    2022$82.0114.2x0.3x1.9x
    2021$82.4016.0x0.4x1.8x
    2020$60.0312.1x0.3x1.4x
    2019$62.8714.2x0.3x2.1x
    2018$57.6516.1x0.4x2.2x
    2017$50.4419.9x0.4x2.6x
    2016$28.2613.0x0.2x1.7x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CNC

    What is CNC's forward P/E ratio?

    Centene has a forward P/E ratio of 12.6x.

    Is CNC stock overvalued?

    GNG's valuation label for CNC is Fairly valued. Its P/E of 14.2x compares with a median of 18.6x across 12 similar companies.

    What is CNC's price to sales ratio?

    Centene has a price to sales ratio of 0.2x.

    What is Centene's average P/E ratio over 5 years?

    Centene's median P/E over the last 5 years is 11.4x, from 60 month-end values through Oct 2026.

    What is CNC's PEG ratio?

    Centene has a PEG ratio of 0.8.